We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-13.49%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$280M
AUM Growth
-$49.2M
(-15%)
Cap. Flow
-$4.11M
Cap. Flow
% of AUM
-1.47%
Top 10 Holdings %
Top 10 Hldgs %
51.06%
Holding
103
New
34
Increased
13
Reduced
15
Closed
27
Top Buys
| 1 |
Amgen
AMGN
|
+$23.2M |
| 2 |
Envista
NVST
|
+$21.9M |
| 3 |
Boston Scientific
BSX
|
+$15.5M |
| 4 |
Biogen
BIIB
|
+$12.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.63M |
Top Sells
| 1 |
Medtronic
MDT
|
+$16.7M |
| 2 |
Pfizer
PFE
|
+$14.9M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$14.8M |
| 4 |
Gilead Sciences
GILD
|
+$12.1M |
| 5 |
GSK
GSK
|
+$9.62M |
Sector Composition
| 1 | Healthcare | 89.17% |
| 2 | Financials | 0.62% |
| 3 | Technology | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Amgen
AMGN
$192B
| $21.5M | 7.68% |
+106,069
| New | +$23.2M |
|
2
McKesson
MCK
$94.1B
| $17.9M | 6.39% |
132,340
+63,901
| +93% | +$9.36M |
|
3
Coherus Oncology
CHRS
$224M
| $17.5M | 6.24% |
1,077,839
+131,078
| +14% | +$2.42M |
|
|
GWPH
4
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $14.7M | 5.25% |
168,044
-17,713
| -10% | -$1.88M |
|
|
5
Biogen
BIIB
$28.3B
| $13.3M | 4.74% |
+41,938
| New | +$12.7M |
|
6
Elevance Health
ELV
$92.7B
| $13.1M | 4.69% |
57,869
+27,130
| +88% | +$7.39M |
|
|
7
Boston Scientific
BSX
$63.4B
| $12.9M | 4.61% |
+395,747
| New | +$15.5M |
|
|
8
Envista
NVST
$4.25B
| $12.8M | 4.57% |
+856,922
| New | +$21.9M |
|
|
AGN
9
DELISTED
Allergan plc
AGN
| $9.74M | 3.48% |
55,000
-41,931
| -43% | -$7.9M |
|
|
10
SPDR Gold Trust
GLD
$131B
| $9.58M | 3.42% |
+64,702
| New | +$9.63M |
|
11
United Therapeutics
UTHR
$22.4B
| $8.61M | 3.07% |
90,823
-41,841
| -32% | -$3.98M |
|
|
BMY.RT
12
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| $8.54M | 3.05% |
+2,246,900
| New | +$7.4M |
|
13
Vanda Pharmaceuticals
VNDA
$352M
| $7.47M | 2.67% |
+721,193
| New | +$8.94M |
|
14
Merck
MRK
$298B
| $7.16M | 2.56% |
97,551
-80,352
| -45% | -$6.32M |
|
15
HCA Healthcare
HCA
$80.7B
| $7M | 2.5% |
77,932
-31,667
| -29% | -$4.1M |
|
|
NBP
16
NovaBridge Biosciences American Depositary Shares
NBP
$208M
| $6.14M | 2.19% |
+472,675
| New | +$5.91M |
|
17
UnitedHealth
UNH
$386B
| $5.46M | 1.95% |
+21,900
| New | +$6.03M |
|
18
Teva Pharmaceuticals
TEVA
$37.1B
| $5.14M | 1.84% |
+572,681
| New | +$5.87M |
|
|
RDUS
19
DELISTED
Radius Health, Inc.
RDUS
| $5.04M | 1.8% |
387,402
+287,402
| +287% | +$5.12M |
|
20
Molina Healthcare
MOH
$12.6B
| $5.03M | 1.79% |
35,973
-37,263
| -51% | -$4.99M |
|
21
Zimmer Biomet
ZBH
$17.6B
| $4.75M | 1.7% |
+48,410
| New | +$6.35M |
|
22
Quanterix
QTRX
$192M
| $4.36M | 1.55% |
+237,081
| New | +$5.41M |
|
|
LITS
23
Lite Strategy Inc
LITS
$33.9M
| $4M | 1.43% |
124,255
+4,312
| +4% | +$172K |
|
|
ARNA
24
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.58M | 1.28% |
85,153
-4,204
| -5% | -$193K |
|
25
Ardelyx
ARDX
$1.27B
| $3.53M | 1.26% |
621,534
| – | – |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA